New FDA seasonal COVID-19 shot guidance seeks ‘evidence based’ approach
The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for evidence" of their effectiveness for the masses.
What you need to know about the COVID-19’s pandemic’s effects on America’s economy, and what it means for your finances.
The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for evidence" of their effectiveness for the masses.